Use and persistence of single and multiple inhaler triple therapy prescribed for patients with COPD in France: a retrospective study on THIN database (OPTI study)
Introduction From 2018 single inhaler triple therapy (SITT) became available in France to treat moderate-to-severe chronic obstructive pulmonary disease (COPD). Given its simplified inhaler use compared with multiple inhaler triple therapy (MITT), this therapeutic option has the potential to offer b...
Main Authors: | Gaëtan Deslee, Andrew Maguire, Gabriel Thabut, Caroline Fabry-Vendrand, Nolwenn Poccardi, Caroline Eteve Pitsaer, Adrien Coriat, Charlotte Renaudat, Thomas Pinto |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-12-01
|
Series: | BMJ Open Respiratory Research |
Online Access: | https://bmjopenrespres.bmj.com/content/10/1/e001585.full |
Similar Items
-
Current appraisal of single inhaler triple therapy in COPD
by: Lipworth B, et al.
Published: (2018-09-01) -
Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD
by: Bourbeau J, et al.
Published: (2021-03-01) -
The IMPACT of triple versus dual single-inhaler therapy on exacerbations of COPD
by: Claudia C. Dobler
Published: (2018-12-01) -
Preventing clinically important deterioration with single-inhaler triple therapy in COPD
by: Ian Naya, et al.
Published: (2018-10-01) -
Economic impact of implementing prescription of single-inhaler triple therapies versus current multiple-inhaler triple therapies for COPD in the Apulia Region
by: Emanuela Resta, et al.
Published: (2022-10-01)